Royal Bank Of Canada Concert Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $374,667 - $504,161	86,329 Added 9776.78%	87,212 $509,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $3,599 - $6,069	843 Added 2107.5%	883 $5,000
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $107 - $168	40 New	40 $0
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $7,142 - $9,349	-2,253 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $8,493 - $11,805	2,253 New	2,253 $10,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.